HOPKINTON, Mass., Jan. 5 /PRNewswire-FirstCall/ -- Caliper Life Sciences, Inc. today announced that its presentation at the JPMorgan 24th Annual Healthcare Conference will be webcast on Thursday, January 12 at 12:30 p.m. PST. Kevin Hrusovsky, President and CEO of Caliper, will be presenting. The live webcast can be accessed at http://equityconferences.jpmorgan.com . An archived presentation will be available for 90 days.
About Caliper Life Sciences
Caliper Life Sciences uses its leading microfluidics patent estate, innovative automation technologies, and broad assay expertise to accelerate drug discovery, enable diagnosis of disease and facilitate scientific research. With the acquisition of NovaScreen Biosciences in October 2005, Caliper became the first company to provide a comprehensive, central resource for drug discovery products and services.
Caliper headquarters are located in Hopkinton, MA, with R&D, operations and manufacturing facilities for LabChip devices in Mountain View, CA, NovaScreen service operations in Hanover, MD and direct sales, service and applications support throughout the world. The company’s customers and “Caliper Driven” partners include many of the largest pharmaceutical, biotechnology, and life sciences companies. www.caliperLS.com
Caliper Life Sciences, Inc.
CONTACT: Michele Boudreau of Caliper Life Sciences, Inc., +1-650-623-0305
